Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Blaasstoornis bij MS behandelen met neuromodulatie
mei 2024 | Multipele Sclerose